首页> 美国卫生研究院文献>Journal of Orthopaedic Surgery and Research >PKP/PVP combine chemotherapy in the treatment of multiple myeloma patients with vertebral pathological fractures: minimum 3-year follow-up of 108 cases
【2h】

PKP/PVP combine chemotherapy in the treatment of multiple myeloma patients with vertebral pathological fractures: minimum 3-year follow-up of 108 cases

机译:PKP / PVP联合化学疗法治疗多发性骨髓瘤合并椎体病理性骨折的患者:最少三年随访108例

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundMultiple myeloma (MM) is a blood system malignant tumor, which often leads to osteolytic bone destruction, and the vertebral column is the primary site of involvement. However, the efficacy and prognosis of percutaneous kyphoplasty/vertebroplasty (PKP/PVP) for simple vertebral pathological fractures in patients with multiple myeloma are not yet unified. The primary objective of this study was to investigate the efficacy and prognosis of PKP/PVP in the treatment of multiple myeloma patients with vertebral pathological fractures.
机译:背景多发性骨髓瘤(MM)是一种血液系统恶性肿瘤,通常会导致溶骨性破坏,而脊柱是主要的受累部位。然而,对于多发性骨髓瘤患者的简单椎体病理性骨折,经皮椎体后凸成形术/椎体成形术(PKP / PVP)的疗效和预后尚未统一。这项研究的主要目的是研究PKP / PVP在多发性骨髓瘤合并椎体病理性骨折中的疗效和预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号